Investor Relations

DBV Technologies is a global biopharmaceutical company focused on discovering, developing, manufacturing and commercializing treatments for severe allergies

News

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Events

Citi’s 12th Annual Biotech Conference

Boston, MA, USA

Documentation

20F- Form 2016

Investor Relations

Phone : +33 1 55 42 78 78
Fax : +33 1 43 26 10 83

Subscribe to get the latest DBV’s News